TCL Archive FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment. September 28, 2001
TCL Archive Release of Mayo Pathology Report Would Be Needed To Confirm Stage IIA Diagnosis. October 24, 2008
TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
